Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

17%

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Other(1)

Detailed Status

Completed3

Not yet recruiting1

Recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

not_yet_recruiting117%

completed350%

recruiting117%

unknown117%

Recent Activity

1 active trials

Showing 5 of 6

not_yet_recruitingnot_applicable

Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study

NCT04763993

completedphase_1

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

NCT04381832

recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT04763993Not Applicable

Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study

Not Yet Recruiting

NCT04381832Phase 1

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Completed

NCT04366999

Effectiveness of Bariatric Surgery for NAFLD/NASH

Recruiting

NCT03524365Not Applicable

Bariatric Surgery Versus Non-alcoholic Steato-hepatitis

Completed

NCT03540693

Fat Taste Sensory Study

Unknown

NCT03181347Not Applicable

The Microbiology of Bariatric Surgery

Completed

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6